American Indians are a minority population in the U.S., numbering only about 4.1 million according to year 2000 census figures.1 While most Indians live in cities, a substantial number live in rural settings and earn marginal wages. Although health care is free for Indians, the services tend to be basic and do not include specialized dementia diagnosis and care. Indians are of special interest to the UTSW ADC because of their increasingly high prevalence of obesity, diabetes, hypertension, and cardiovascular disease.2 We have a long-standing relationship with the Choctaw Nation, which covers 15,000 square miles in southeastern Oklahoma, and comprises 80,000 persons. Given our theme of investigating the impact of vascular and inflammatory factors on the onset and course of AD, this is an ideal study population. Over many years, we have developed a strong positive working relationship with these underserved rural minority individuals by providing clinical sen/ices as a quid pro quo for performing research.
The Specific Aims of the Native American Satellite Diagnostic and Treatment Core are: 1. To provide dementia diagnosis and treatment to the Choctaw Nation through in-person visits to Oklahoma and monthly telemedicine clinics staffed by ADC faculty in Dallas and our nurse and clinical educator in Talihina, Oklahoma. 2. To support UT Southwestern investigator-initiated dementia research. We have enabled the conduct of an Alzheimer Association-sponsored investigation of cardiovascular risk factor in Indians with AD. 3. To support telemedicine-based research. We have established the feasibility of telemedicine based clinical care and neuropsychological testing. 4. To support multi-institutional observational studies and clinical trials. We have contributed 40% of the American Indians in the NACC database and have used the NACC database to compare the clinical course of AD in American Indians with that in Caucasians and African Americans.

Public Health Relevance

The development of successful therapies for Alzheimer's disease (AD) will require a thorough understanding of the pathologic mechanisms that contribute to neurodegeneration. Data from epidemiologic and observational studies indicates that vascular and inflammatory pathology contributes to AD. The goal of the UTSW ADC is to identify biomarkers of vascular and inflammatory pathology that will be useful for selection

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Center Core Grants (P30)
Project #
5P30AG012300-19
Application #
8501185
Study Section
Special Emphasis Panel (ZAG1-ZIJ-5)
Project Start
Project End
Budget Start
2013-07-01
Budget End
2014-06-30
Support Year
19
Fiscal Year
2013
Total Cost
$175,483
Indirect Cost
$24,166
Name
University of Texas Sw Medical Center Dallas
Department
Type
DUNS #
800771545
City
Dallas
State
TX
Country
United States
Zip Code
75390
Burke, Shanna L; Maramaldi, Peter; Cadet, Tamara et al. (2018) Decreasing hazards of Alzheimer's disease with the use of antidepressants: mitigating the risk of depression and apolipoprotein E. Int J Geriatr Psychiatry 33:200-211
Qian, Winnie; Fischer, Corinne E; Schweizer, Tom A et al. (2018) Association Between Psychosis Phenotype and APOE Genotype on the Clinical Profiles of Alzheimer's Disease. Curr Alzheimer Res 15:187-194
Gallagher, Damien; Kiss, Alex; Lanctot, Krista et al. (2018) Depression and Risk of Alzheimer Dementia: A Longitudinal Analysis to Determine Predictors of Increased Risk among Older Adults with Depression. Am J Geriatr Psychiatry 26:819-827
Haaksma, Miriam L; Calderón-Larrañaga, Amaia; Olde Rikkert, Marcel G M et al. (2018) Cognitive and functional progression in Alzheimer disease: A prediction model of latent classes. Int J Geriatr Psychiatry 33:1057-1064
Ramsey, Christine M; Gnjidic, Danijela; Agogo, George O et al. (2018) Longitudinal patterns of potentially inappropriate medication use following incident dementia diagnosis. Alzheimers Dement (N Y) 4:1-10
Hadjichrysanthou, Christoforos; McRae-McKee, Kevin; Evans, Stephanie et al. (2018) Potential Factors Associated with Cognitive Improvement of Individuals Diagnosed with Mild Cognitive Impairment or Dementia in Longitudinal Studies. J Alzheimers Dis 66:587-600
Hanfelt, John J; Peng, Limin; Goldstein, Felicia C et al. (2018) Latent classes of mild cognitive impairment are associated with clinical outcomes and neuropathology: Analysis of data from the National Alzheimer's Coordinating Center. Neurobiol Dis 117:62-71
Zhou, Zilu; Wang, Weixin; Wang, Li-San et al. (2018) Integrative DNA copy number detection and genotyping from sequencing and array-based platforms. Bioinformatics 34:2349-2355
Stallings, Nancy R; O'Neal, Melissa A; Hu, Jie et al. (2018) Pin1 mediates A?42-induced dendritic spine loss. Sci Signal 11:
Burke, Shanna L; Hu, Tianyan; Fava, Nicole M et al. (2018) Sex differences in the development of mild cognitive impairment and probable Alzheimer's disease as predicted by hippocampal volume or white matter hyperintensities. J Women Aging :1-25

Showing the most recent 10 out of 385 publications